Back To Top

You have matched to 1 trial

Guest Profile:  No profile selected

Copy link
Sort by zip code: 94107 Hide Map Icon
mail-icon

Register to sign up for Trial Alerts

Receive emails about new trials that match your profile.
1

TheraBionic P1 Device for Women with Advanced Hormone Receptor Positive (ER+ and/or PR+), HER2 Negative (HER2-) Breast Cancer

A Phase 2 Study of TheraBionic P1 Device for Patients With Metastatic Hormone Positive Breast Cancer Post Endocrine Therapy

Purpose: To study the safety, effects (good and bad), and anti cancer activity of the TheraBionic P1, a device that delivers low level electromagnetic fields (a type of energy), to see whether it can slow the growth or spread of breast cancer.

Who is this for?: Women 22 years or older with advanced (some stage III) or metastatic (stage IV) hormone receptor positive (ER+ and/or PR+), HER2 negative (HER2-) breast cancer. Your cancer must have progressed after treatment, or you were unable to tolerate treatment. This includes at least one type of hormone therapy given with a CDK4/6 inhibitor, and at least one type of chemotherapy and/or antibody drug conjugate (ADC). View full eligibility criteria

What's involved?

<p class="seamTextPara"> You will be asked to do the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">You will give yourself treatment with the TheraBionic P1 device at home</li> <li class="seamTextUnorderedListItem">You will use the device in three 60 minute sessions each day: once in the morning, once in the middle of the day, and once in the evening</li></ul>

What's being studied?

<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This trial is studying the TheraBionic P1 device as a treatment for breast cancer. </li> <li class="seamTextUnorderedListItem">The device delivers low level, amplitude modulated electromagnetic fields (a type of energy).</li></ul>

How can I learn more?

<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07227831' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.therabionic.com/' target='_blank'>TheraBionic Inc.: TheraBionic P1 therapy is a new FDA-approved treatment when other cancer therapies have failed</a> </li></ul>
1

TheraBionic P1 Device for Women with Advanced Hormone Receptor Positive (ER+ and/or PR+), HER2 Negative (HER2-) Breast Cancer

A Phase 2 Study of TheraBionic P1 Device for Patients With Metastatic Hormone Positive Breast Cancer Post Endocrine Therapy
Icon

Nearest Location from 94107:
1989 miles
Karmanos Cancer Institute at McLaren Northern
Petoskey, MI

Icon

Visits:
Number of visits unavailable

Icon

ClinicalTrials.gov: NCT07227831

Icon

Phase NA

HELP GUIDE